Download presentation
Presentation is loading. Please wait.
Published byJob Waters Modified over 6 years ago
1
Postoperative neutrophil-to-lymphocyte ratio of living-donor liver transplant: Association with graft size Hironori Hayashi, Hiroyuki Takamura, Yoshinao Ohbatake, Shinichi Nakanuma, Isamu Makino, Hisatoshi Nakagawara, Tomoharu Miyashita, Hidehiro Tajima, Sachio Fushida, Tetsuo Ohta Asian Journal of Surgery Volume 39, Issue 2, Pages (April 2016) DOI: /j.asjsur Copyright © Terms and Conditions
2
Figure 1 Changes in the absolute numbers of (A) neutrophils, (B) lymphocytes, (C) platelets, and (D) neutrophil-to-lymphocyte ratio in the recipients using graft volume/standard liver volume under 35% graft group (Group S; closed bars) and in those using graft volume/standard liver volume over 35% graft group (Group L; open bars). The differences in neutrophil-to-lymphocyte ratio between the two groups were significant at postoperative Day 1, Day 7, and Day 10 (p < 0.05), as well as at postoperative Day 3 and Day 5 (p < 0.01). NLR = neutrophil-to-lymphocyte ratio; POD = postoperative day. Asian Journal of Surgery , DOI: ( /j.asjsur ) Copyright © Terms and Conditions
3
Figure 2 Changes in (A) prothrombin time–international normalized ratio, (B) serum total bilirubin level, and (C) C-reactive protein in recipients using graft volume/standard liver volume under 35% graft group (Group S; closed bars) and in those using graft volume/standard liver volume over 35% graft group (Group L; open bars). The difference in prothrombin time–international normalized ratio between the two groups was significant at postoperative Day 1 (p < 0.05). Further, the differences in the total bilirubin levels between the two groups were significant at postoperative Day 3, Day 5, Day 7, and Day 14 (p < 0.05), as well as at postoperative Day 10 (p < 0.01). CRP = C-reactive protein; POD = postoperative day; PT–INR = prothrombin time–international normalized ratio; T-Bil. = total bilirubin. Asian Journal of Surgery , DOI: ( /j.asjsur ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.